Target intelligence / Profile preview

Pathogenic Activated CD4 T Cell

Molecular classification
Cell, T lymphocyte, CD4+ T cell, Effector cell, Cytokine producer
01

Overview

Pathogenic activated CD4 T cells are a subset of CD4+ T lymphocytes that, upon activation by antigen presentation, contribute to immune responses but can also drive pathological processes such as autoimmunity and chronic inflammation. These cells are distinguished from normal helper or regulatory CD4+ T cells by their pro-inflammatory cytokine profiles and their role in mediating tissue damage. They are central players in many autoimmune diseases and are targets for immunomodulatory therapies aiming to restore balance between effector and regulatory arms of the adaptive immune system.

Other names
Pro-inflammatory CD4 T cellAutoimmune CD4 T cellTh1 cellTh17 cell
02

Mechanism of action

Inhibition of T cell activation, depletion of T cells, neutralization of pro-inflammatory cytokines, or modulation of T cell signaling pathways.

03

Biological functions

Immune responseAdaptive immunityCytokine secretionInflammationT cell activationAntigen presentation response
04

Disease associations

Autoimmune diseaseChronic inflammationMultiple sclerosisRheumatoid arthritisType 1 diabetes mellitusCeliac disease
05

Safety considerations

Increased risk of infectionIncreased risk of malignancyImmune suppressionCytokine release syndrome
06

Interacting drugs

Immunosuppressants

4 more in the full profile.

07

Biomarkers

IFN-γ levelsIL-17A levelsExpression of Th1/Th17-associated transcription factors (T-bet, RORγt)CD4+ T cell countPresence of autoreactive T cell clones

Beyond the preview

Go deeper on Pathogenic Activated CD4 T Cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic Activated CD4 T Cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call